ELECTROCORE INC (ECOR)
US28531P2020 - Common Stock
We assign a fundamental rating of 3 out of 10 to ECOR. ECOR was compared to 192 industry peers in the Health Care Equipment & Supplies industry. The financial health of ECOR is average, but there are quite some concerns on its profitability. ECOR is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
ECOR had negative earnings in the past year.
In the past year ECOR has reported a negative cash flow from operations.
ECOR had negative earnings in each of the past 5 years.
ECOR had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ECOR's Return On Assets of -116.95% is on the low side compared to the rest of the industry. ECOR is outperformed by 84.38% of its industry peers.
ECOR's Return On Equity of -253.05% is on the low side compared to the rest of the industry. ECOR is outperformed by 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -116.95% | ||
| ROE | -253.05% | ||
| ROIC | N/A |
ROA(3y)-82.22%
ROA(5y)-89.72%
ROE(3y)-143.24%
ROE(5y)-143.6%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 82.53%, ECOR belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
ECOR's Gross Margin has improved in the last couple of years.
ECOR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 82.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.95%
GM growth 5Y14.78%
2. Health
2.1 Basic Checks
ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ECOR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ECOR has more shares outstanding
There is no outstanding debt for ECOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -14.27, we must say that ECOR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -14.27, ECOR is doing worse than 85.94% of the companies in the same industry.
There is no outstanding debt for ECOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -14.27 |
ROIC/WACCN/A
WACC10.01%
2.3 Liquidity
ECOR has a Current Ratio of 1.76. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.76, ECOR is not doing good in the industry: 78.65% of the companies in the same industry are doing better.
ECOR has a Quick Ratio of 1.49. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.
ECOR has a Quick ratio of 1.49. This is in the lower half of the industry: ECOR underperforms 70.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.49 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.14% over the past year.
ECOR shows a strong growth in Revenue. In the last year, the Revenue has grown by 86.41%.
The Revenue has been growing by 74.53% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)26.14%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q50%
Revenue 1Y (TTM)86.41%
Revenue growth 3Y66.07%
Revenue growth 5Y74.53%
Revenue growth Q2Q102.77%
3.2 Future
ECOR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.65% yearly.
Based on estimates for the next years, ECOR will show a very strong growth in Revenue. The Revenue will grow by 34.98% on average per year.
EPS Next Y45.78%
EPS Next 2Y34.95%
EPS Next 3Y26.65%
EPS Next 5YN/A
Revenue Next Year49.34%
Revenue Next 2Y45.94%
Revenue Next 3Y45.9%
Revenue Next 5Y34.98%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ECOR. In the last year negative earnings were reported.
Also next year ECOR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ECOR's earnings are expected to grow with 26.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.95%
EPS Next 3Y26.65%
5. Dividend
5.1 Amount
ECOR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ELECTROCORE INC
NASDAQ:ECOR (5/1/2024, 7:00:01 PM)
6.04
-0.2 (-3.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap36.24M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -116.95% | ||
| ROE | -253.05% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 82.53% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.49 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)26.14%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y45.78%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)86.41%
Revenue growth 3Y66.07%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y